Research News and Research

RSS

VA streamlining Agent Orange claims process

USA Today: "The Department of Veterans Affairs plans to announce today that it will fully automate how it pays claims for illnesses related to exposure to the chemical Agent Orange to keep an overburdened system from collapse.

9 Mar 2010

ETEX receives FDA marketing clearance for CarriGen Porous Bone Substitute Material

ETEX Corporation, an advanced biomaterials company, announced today that the FDA has granted 510(k) clearance of CarriGen® Porous Bone Substitute Material. CarriGen is available for immediate sale through ETEX's independent sales force. CarriGen builds upon the clinically proven benefit of ETEX nanocrystalline calcium phosphate technology by adding the advantage of increased porosity and pore size. CarriGen is the first highly porous bone graft substitute that sets hard upon implantation for a complete defect fill.

9 Mar 2010

Americans for Tax Reform asks for clarification on applicability of 2.9% surtax on capital gains

Americans for Tax Reform today sent a letter to President Obama asking him to clarify whether or not the 2.9 percent surtax on "unearned income" applies to capital gains. If Obama's tax increase does fall on capital gains, the marginal tax rate on capital gains will eventually rise to 22.9 percent from today's level of 15 percent.

9 Mar 2010

Domiciliary parenteral nutrition helps children with serious intestinal problems live more normally

Children with serious intestinal problems have to be fed intravenously. There moreover, exist systems that enable intravenous feeding to be carried out at home. Mr I-aki Irastorza, paediatrician at the Cruces hospital in Bilbao, spent some 15 years analysing how serious intestinal problems in children were treated at the Great Ormond Street Children's Hospital in London. With the gathered data he has presented a highly novel PhD thesis at the University of the Basque Country.

9 Mar 2010

TechniScan commences study with WBU system for automated breast ultrasound imaging

TechniScan, Inc., a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, today announced that it has commenced phase two of its grant study at the University of California, San Diego (UCSD) Moores Cancer Center.

9 Mar 2010

Study validates Chronix Biomedical’s serum DNA blood tests for early, accurate detection of breast cancer

Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests for the early and accurate detection of breast cancer. The Chronix tests detect the circulating DNA that is released into the blood stream by damaged and dying cells. A growing body of publications from Chronix and other researchers shows that this circulating DNA can be identified and analyzed to provide a diagnostic window into ongoing changes in the genome associated with specific diseases—changes that can be used to identify disease processes at an early stage and to track responses to treatment.

9 Mar 2010

First Edition: March 9, 2010

Today's headlines reflect the latest news on President Obama's effort to build support -- both among the public and lawmakers-- for his health plan. Meanwhile, the GOP pledges to make the reform face off a key issue in the midterm elections.

9 Mar 2010

Orexigen Therapeutics reports net loss of $15.0M for three months ended December 31, 2009

Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the three months and year ended December 31, 2009.

9 Mar 2010

"Cyberbullying" leads to depression in LGBT youth

Schools are typically on guard against students who bully by inflicting repeated violence on other students. But technology has given rise to a relatively new form of bullying which inflicts emotional harm in a stealth manner, working through Web sites, chat rooms, e-mail, cell phones and instant messaging.

9 Mar 2010

Type of specialist that men with prostate cancer see can influence form of therapy they ultimately receive

New research published in today's issue of the Archives of Internal Medicine (Vol. 170, No. 5), by an investigator at The Cancer Institute of New Jersey and colleagues at Memorial Sloan-Kettering Cancer Center in New York, shows that the type of specialist that men with localized prostate cancer see can influence the form of therapy they ultimately receive.

9 Mar 2010

Novel protein haditoxin in King Cobra's venom discovered

The King Cobra continues to weave its charm with researchers identifying a protein in its venom with the potential for new drug discovery and to advance understanding of disease mechanisms.

9 Mar 2010

Study focuses on disability and employment among working-age immigrants in the U.S.

Currently, foreign-born people make up approximately 13 percent of the total U.S. population. As the immigrant population grows, understanding its disability status and employment characteristics becomes increasingly important.

9 Mar 2010

Keeping pace with emerging health-care advances and tracking progress on achieving learning goals

Physicians would be better prepared for the accelerating rate of scientific discovery - and more in step with the latest in patient-care - if they added an important tool to their medical bags: a plan for how to keep pace with emerging health-care advances.

9 Mar 2010

Three graduate students to receive 2010 AIBS Emerging Public Policy Leadership Award

The American Institute of Biological Sciences has selected Meredith Niles, a graduate student at the University of California, Davis, Ryan Richards, a graduate student at the University of Maryland, College Park, and Leslie Smith, a graduate student at the University of Rhode Island, to receive the 2010 AIBS Emerging Public Policy Leadership Award.

9 Mar 2010

MicroConstants acquires access to new nanosizing technology

MicroConstants, a GLP-compliant Contract Research Organization specializing in bioanalytical and pharmacokinetic analysis, has acquired access to a new nanosizing technology that transforms water insoluble compounds into nanoparticles, making formulation preparation and dosing for toxicology studies easier.

9 Mar 2010

March designated as 'National Autoimmune Diseases Awareness Month'

On the evening of March 4, 2010, the U.S. Senate passed a resolution designating March as "National Autoimmune Diseases Awareness Month" and supporting efforts to increase awareness of autoimmune diseases and increase funding for autoimmune disease research. The Senate resolution (S.RES.372) was introduced by Michigan Senator Carl Levin on December 8, 2009.

9 Mar 2010

Rush University Medical Center develops WISHFIT program to help pre-menopausal women reduce visceral fat

Under a $7.1 million grant from the National Institutes of Health, Rush University Medical Center is developing a novel program, called WISHFIT, to help pre-menopausal women reduce visceral fat through a sustained increase in physical activity and reduction in stress.

9 Mar 2010

Ingenuity Systems announces Molecule Scientific as exclusive distributor of IPA in Taiwan

Ingenuity Systems, the leading provider of information solutions for life science researchers, today announced Molecule Scientific Co., Ltd. as the exclusive distributor of IPA® in Taiwan.

9 Mar 2010

Exelixis fourth-quarter revenues rise from $29.6M to $44.1M

Exelixis, Inc. today reported financial results for the fourth quarter and year ended December 31, 2009.

9 Mar 2010

Sartorius achieves operating earnings of 60.9M euros for 2009

Sartorius, a leading international laboratory and process equipment provider, increased its operating profit in 2009 despite the difficult macroeconomic climate and achieved operating earnings of 60.9 million euros, up from 56.8 million euros a year earlier. “As a result, we are among the companies that were able to close the 2009 year of crisis with a positive development of operating earnings,” commented CEO Dr. Joachim Kreuzburg on the company’s full-year results at the annual press conference in Goettingen, Germany.

From Sartorius 9 Mar 2010

Research News and Research

VA streamlining Agent Orange claims process

ETEX receives FDA marketing clearance for CarriGen Porous Bone Substitute Material

Americans for Tax Reform asks for clarification on applicability of 2.9% surtax on capital gains

Domiciliary parenteral nutrition helps children with serious intestinal problems live more normally

TechniScan commences study with WBU system for automated breast ultrasound imaging

Study validates Chronix Biomedical’s serum DNA blood tests for early, accurate detection of breast cancer

First Edition: March 9, 2010

Orexigen Therapeutics reports net loss of $15.0M for three months ended December 31, 2009

"Cyberbullying" leads to depression in LGBT youth

Type of specialist that men with prostate cancer see can influence form of therapy they ultimately receive

Novel protein haditoxin in King Cobra's venom discovered

Study focuses on disability and employment among working-age immigrants in the U.S.

Keeping pace with emerging health-care advances and tracking progress on achieving learning goals

Three graduate students to receive 2010 AIBS Emerging Public Policy Leadership Award

MicroConstants acquires access to new nanosizing technology

March designated as 'National Autoimmune Diseases Awareness Month'

Rush University Medical Center develops WISHFIT program to help pre-menopausal women reduce visceral fat

Ingenuity Systems announces Molecule Scientific as exclusive distributor of IPA in Taiwan

Exelixis fourth-quarter revenues rise from $29.6M to $44.1M

Sartorius achieves operating earnings of 60.9M euros for 2009

A guide to advancing biotherapeutic research eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence